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Abstract
Background: Mitochondria are highly dynamic organelles whose morphology and position within the cell is
tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial
morphology and the mechanisms that govern mitochondrial dynamics are poorly understood. However, recent
evidence indicates that the core machinery that governs mitochondrial dynamics is linked within complex
intracellular signalling cascades, including apoptotic pathways, cell cycle transitions and nuclear factor kappa B
activation. Given the emerging importance of mitochondrial plasticity in cell signalling pathways and metabolism,
it is essential that we develop tools to quantitatively analyse the processes of fission and fusion. In terms of
mitochondrial fusion, the field currently relies upon on semi-quantitative assays which, even under optimal
conditions, are labour-intensive, low-throughput and require complex imaging techniques.
Results: In order to overcome these technical limitations, we have developed a new, highly quantitative cell-free
assay for mitochondrial fusion in mammalian cells. This assay system has allowed us to establish the energetic
requirements for mitochondrial fusion. In addition, our data reveal a dependence on active protein
phosphorylation for mitochondrial fusion, confirming emerging evidence that mitochondrial fusion is tightly
integrated within the global cellular response to signaling events. Indeed, we have shown that cytosol derived
from cells stimulated with different triggers either enhance or inhibit the cell-free fusion reaction.
Conclusions: The adaptation of this system to high-throughput analysis will provide an unprecedented
opportunity to identify and characterize novel regulatory factors. In addition, it provides a framework for a detailed
mechanistic analysis of the process of mitochondrial fusion and the various axis of regulation that impinge upon
this process in a wide range of cellular conditions.
See Commentary: http://www.biomedcentral.com/1741-7007/8/99
Background
Mitochondria are highly dynamic organelles, whose plas-
ticity allows them to respond quickly to cellular cues
that regulate their cellular position, interconnectivity
and function [1]. In this way, the dynamic behaviour of
the mitochondria must be tightly coupled to cellular sig-
nalling cascades in order to respond in such a coordi-
nated fashion. The molecular mechanisms that govern
mitochondrial fusion have been best described using
yeast genetics, where genome-wide screens have
identified the essential components of the fusion reac-
tion [2-4]. In addition to these genetic screens, a cell-
free mitochondrial fusion assay has been developed
using yeast mitochondria labelled with various fluores-
cent markers within the matrix and outer membranes
[5]. This assay has provided important insights into the
s p e c i f i cr o l eo ft h ef u s i o nG T P a s e sF z o 1a n dM g m 1 ,
along with the multispanning membrane protein Ugo1,
in the regulation of mitochondrial docking, outer mem-
brane and inner membrane fusion [5-7]. The yeast assay
has, therefore, been critical in order to stage the reac-
tion and follow mitochondrial docking and membrane
fusion. However, this fluorescent output relies upon the
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any medium, provided the original work is properly cited.direct user-based quantification of fused organelles using
microscopy techniques, which has not been amenable to
high-throughput screening and automation.
In contrast to the yeast model, one of the primary
limitations in the study of mitochondrial dynamics in
the mammalian system has been the reliance on semi-
quantitative microscopic analysis of mitochondrial
phenotypes within cells. Changes in mitochondrial
morphology are quantified primarily using a subjective
classification between ‘fragmented’ and ‘fused’.T h e s e
classifications cannot distinguish whether the observed
phenotypes are the result of changes in fusion or
fission (or both) and many cell types exhibit fused
mitochondria under standard conditions, making
quantification of morphology rather like examining
spaghetti in a bowl. Two more quantitative approaches
have been used to examine mitochondrial fusion, the
polyethylene glycol induced whole cell fusion that
allows the fusion between two differentially labelled
populations of mitochondria [8,9], and the photoactiva-
tible-GFP based assay, where small populations of
mitochondria are fluorescently activated and their
subsequent fusion events scored using fluorescent
quantification [10,11]. Although superior to direct
morphology analysis, these two methods are not very
robust, and suffer from a number of technical issues.
For example, the polyethylene glycol fusion itself
probably affects the kinetics of mitochondrial fusion
and the required addition of cyclohexamide is proble-
matic for many applications. The PA-GFP assay takes
many hours to obtain convincing results from just a
single cell, making statistical analysis very tedious.
These technical issues make limited progress in the
field of mitochondrial fusion, thus making it virtually
impossible to identify and dissect the unique stages of
the reaction, experiments which are routinely performed
in other membrane fusion systems [12]. In addition, the
inability to readily quantify mitochondrial fusion has
made it difficult for scientists outside the field to investi-
gate the contribution of mitochondrial fusion to multi-
ple cellular processes. It is clear that mitochondrial
dynamics plays an important role in many diseases,
most notably Parkinson’s Disease and other neurodegen-
erative conditions [13], as well as metabolic disorders
such as diabetes [14]. The integration of scientists from
these fields into the study of mitochondrial dynamics
will depend upon the availability of robust assay systems
to quantify mitochondrial fusion. Therefore, we have
developed a new assay that uses a standard Renilla luci-
f e r a s ea s s a yf o rt h eq u a n t i f ication of matrix-content
mixing [15], providing a platform for scientists from
diverse fields to examine the role of mitochondrial
fusion in cell physiology and disease progression.
Results and discussion
Generation of a bimolecular complementation marker
pair for the quantification of mitochondrial fusion
In order to develop a high-throughput mitochondrial
fusion assay, we adapted a bimolecular complementation
strategy that would allow multiple outputs [15]. cDNAs
were generated encoding mitochondrial targeted split
Venus and Renilla luciferase separated by a leucine zip-
per. Fusion between mitochondria expressing each of
these chimeric proteins would lead to their dimerization
through the leucine zipper motifs, promoting the func-
tional assembly of both luciferase and Venus yellow
fluorescent protein (YFP) [16,17]. These constructs were
designated N-MitoVZL (venus-zipper-luciferase) and
C-MitoLZV (luciferase-zipper-venus; Figure 1a).
The constructs were used to generate two popula-
tions of stable suspension HeLa (sHeLa) cell lines,
each expressing one of the split constructs. One litre
of each stable line of sHeLa cells was grown to conflu-
ence and harvested by centrifugation and mitochondria
were purified by differential centrifugation and flash
frozen at -80°C.
As mitochondria are known to function quite well
in vitro, most notably for metabolic and import reac-
tions, we based the conditions of our assay on estab-
lished buffering and energizing conditions [18,19].
Mitochondria of each population (50 μg each) were
incubated with 5 mg/mL cytosol, GTP (0.5 mM) and an
adenosine triphosphatase/succinate mixture, in a final
volume of 25 μL. After mixing, the mitochondria were
first concentrated by centrifugation and incubated on
ice for 30 min. As reported in the yeast cell-free mito-
chondrial fusion assay, this step helps to facilitate mito-
chondrial docking [5], thereby enhancing the reaction.
Following this step, the mitochondria were resuspended
within the reaction buffer and incubated at 37°C for
30 min. Following the reaction, the extent of mitochon-
drial matrix content mixing could be detected by confo-
cal or electron microscopy (Figure 1), or using a
luciferase assay (Figure 2). For confocal imaging, the
fusion reaction included MitofluorRed633 to label all of
the respiring mitochondria. In order to quench potential
background complementation that might occur due to
the presence of ruptured mitochondria, 25 μgt r y p s i n
was added following the fusion reaction and incubated
on ice for 20 min. This treatment also resulted in the
dispersal of mitochondria, which helped to resolve the
f u s e dm i t o c h o n d r i ab ym i c r o s c o p y( n o ts h o w n ) .T h e
trypsin was then inactivated by incubation with soy
bean trypsin inhibitor for a further 20 min on ice.
Finally, the mixture was mounted on slides and imaged
by confocal microscopy (Figure 1b). The mitochondria
were first identified using the potentiometric dye and
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Page 2 of 12fused mitochondria, which represented 12% (+/- 2.4%)
o ft h ee n t i r ep o p u l a t i o n ,w e r eo b s e r v e dt h r o u g ht h e
visualization of the Venus YFP fluorescence (Figure 1b).
These data reveal the complementation of Venus YFP
within the matrix of fused mitochondria. In order to
test whether mitochondrial fusion is nucleotide depen-
dent, we added apyrase directly into the fusion reaction
to deplete NTPs. This control reaction in the absence of
energy revealed significantly fewer fused mitochondria
within a field (4.0 +/- 2.0%).
As a second output to quantify mitochondrial fusion,
we decided to quantify any changes in the size of the
mitochondria [5]. In order to examine this, we prepared
fusion reactions performed at 4°, where docking should
be facilitated, and reactions performed at 37°, for analy-
sis by electron microscopy (EM). The trypsinization of
the fusion reaction was omitted for this EM analysis to
minimize the required steps. As can be seen in Figure
3a, the light membrane preparation of mitochondria
used in our assays do contain other organelles. Western
Figure 1 Design of a bimolecular complementation assay to quantify mitochondrial fusion. (a) Schematic representation of the
bimolecular complementation strategy used in the development of the mitochondrial cell free fusion assay. (b) Isolated mitochondria were
incubated in the presence of 5 mg/mL placental cytosol and energy regeneration mixture for 30 min at either 37° in the absence (top panels) or
presence (bottom panels) of apyrase. Confocal images of each reaction revealed the presence of respiring mitochondria labelled with
MitofluorRed633 (middle panels). Fused mitochondria show complementation of Venus yellow fluorescent protein (YFP; right panels). Insets in
the top panels show a 2.4× magnification of the area represented within the boxed region. Circled regions show mitochondria positive for
Venus YFP and the arrow within the inset highlights a fused mitochondrion beside one that has not complemented the Venus fluorescence.
Representative images are shown, scale bars, 10 μ. A Gaussian blur filter of 1 pixel was applied to these images. (c) Quantification of (b) taken
from 200-350 mitochondria per condition. The data are the average of two independent experiments.
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Page 3 of 12Figure 2 Complementation of Renilla luciferase demonstrates the core requirements for mitochondrial fusion. (a) The relative luciferase
units (RLU) from the Renilla luciferase assay demonstrates that mitochondrial fusion requires physiological temperature and energy. Sonication of
the basal fusion containing 5 mg/mL cytosol for 5 min, performed in the absence of trypsin, provided a maximum complementation of the
reporter constructs to determine the efficiency of the reaction. Negative controls performed in the presence of apyrase or on ice are shown. The
error bars in the histogram (as in all experiments) show the standard deviation of two independent reactions per condition. All conditions were
repeated at least three times in duplicate. (b) Time course of the fusion reaction, as indicated. (c) Nucleotide dependence of the fusion reaction
in the presence of 1 mM ATPgS, 1 mM GTPgS and in the absence of exogenous GTP, as indicated. (d) Mitochondrial fusion in the presence of
2 μM CCCP, 1 μM Valinomycin and 2 μM nigiricin demonstrates the dependence of the reaction on the charge gradient across the inner
membrane.
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enriched for mitochondria (anti-TOM20) and there was
an absence of contaminating cytosol as indicated by the
loss of tubulin signal (Additional File 1: Figure S1). Ana-
lysis of other organelle markers revealed the preparation
was devoid of early endosomes and golgi, but retained
ER and lysosomal markers (Additional File 1: Figure S1).
The mitochondria within the preparation were largely
intact, as indicated by the asterisks shown in Figure 3a.
The majority of the mitochondria in these preparations
are circular, with over 80% having a length:width ratio
of 1:1 (not shown). When incubated at 4°, the mito-
chondrial diameter averages 500 nm. This diameter is
increased upon incubation at 37°, with organelles regu-
larly spanning 1 to 1.5 microns (Figure 3b). We quanti-
fied the size of 300 mitochondria from a fusion reaction
Figure 3 Ultrastructural quantification of mitochondrial fusion in vitro. Fusion reactions performed in the absence of cytosol were scaled
up to 50 μL and incubated either at 37° or 4°C. Mitochondria were re-isolated and embedded in low-melting agarose for electron microscopy
analysis. (a) A representative section from the reaction incubated at 4°C (left panel), or 37°C (right panel). Asterisks point to intact, healthy
mitochondria. Scale bars are 500 nm. (b) Quantification of the mitochondrial size, binned into 300 nm units. The data are representative of >300
mitochondria in each condition.
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categories. The data show that upon incubation at 37°C,
there is an increase in the pool of mitochondria greater
than 600 nm, from 21% to 44% of organelles counted
(Figure 3b). This number is higher than the 12%
observed by confocal imaging, however it should be
noted that the complementation of Venus YFP can only
be seen with the fusion of the N-MitoVZL with C-
MitoLZV, where any homotypic fusion events will not
be scored. However, the EM analysis scores all mito-
chondria, which may explain the increased numbers of
larger organelles.
Mitochondrial fusion is dependent on nucleotide
hydrolysis and requires a charge gradient across the
inner membrane
The confocal imaging confirmed the complementation
of the Venus fluorescent protein (Figure 1), and the
EM analysis demonstrated an increase in overall mito-
chondrial length (Figure 3). While these two outputs
confirm the specificity of the assay, our main objective
was to utilize the Renilla luciferase activity to provide
ar o b u s ta n dh i g ht h r o u g h p u tm e t h o dt os c o r ef o r
mitochondrial fusion, with a very high signal-to-noise
ratio. Figure 2a shows a representative reaction, where
the basal reaction, containing cytosol, GTP and adeno-
sine triphosphate regenerating system results in a sig-
nal around 35,000 relative luciferase units (RLU). Since
our assay conditions also support mitochondrial pro-
tein import [18,20], it was possible that the signal we
obtained may be due to the import of any free, cytoso-
lic marker into the complementary mitochondria. This
was not the case since the incubation of N-MitoVZL
with cytosols taken from cells expressing C-MitoLZV,
or visa versa, did not result in any signal (Additional
File 1: Figure S2).
The absolute value of RLU obtained in the assay
depended primarily on two factors. First, each mito-
chondrial preparation had a different load of the labels.
Second, and perhaps more importantly, over the course
of this study it became apparent that the length of time
t h em i t o c h o n d r i aw e r el e f to ni c ep r i o rt os t a r t i n gt h e
reaction could reduce the efficiency of fusion. The
dependencies on temperature and energy were unaf-
fected, but the total values would decrease. Therefore it
was important to use the mitochondria within the first
30-60 minutes of thawing them out (data not shown).
In order to test whether mitochondrial fusion is
nucleotide and temperature dependent, we again added
0.1 U/μL apyrase, and performed a reaction at 4°C. As
expected, mitochondrial fusion was not supported in the
absence of energy, with ~400 RLU. Similarly, mitochon-
drial fusion required physiological temperature, with a
reaction performed on ice resulting in only ~1200 RLU
(Figure 2a). These results establish that the enzymatic
amplification of the signal provides a very clear signal-
to-noise ratio, which is essential for a high-throughput
design. In order to estimate the efficiency of mitochon-
drial fusion in vitro, we disrupted all of the mitochon-
dria within the reaction using 5 min pulses of
sonification to allow maximum complementation at 37°,
independently of a fusion event. The trypsin step, which
is required to remove any background complementation
coming from broken mitochondria after the reaction,
was omitted in this reaction. With this, we detected
~227,500 RLU. Given that the basal reaction in this
experiment gave 35,000 counts, it indicates that approxi-
mately ~15% of mitochondria were fusing under basal
conditions (Figure 2a). In all of the reactions performed
with this system, the efficiency has been seen to range
between 5%-20%, depending primarily on the mitochon-
drial preparation (not shown). This is similar to other
cell free fusion assay systems, including the yeast mito-
chondrial fusion system [5,21,22]. As mentioned above,
this number is likely an under-representation of the
total efficiency since it only scores for ‘heterotypic’
fusion events.
In a time course to examine the kinetics of mitochon-
drial fusion, we observe a steady increase in the fusion
signal in the first 30 min. However, longer incubation
times led to a decrease in the fusion signal, possibly due
to degradation of the marker pairs (Figure 2b). The
addition of non-hydrolysable analogues ATPgSa n d
GTPgS inhibited mitochondrial fusion, consistent with a
requirement for nucleotide hydrolysis. Omission of
exogenous GTP led to a twofold reduction in fusion,
suggesting that endogenous GTP within the mitochon-
dria is limited and required for mitochondrial fusion
(Figure 2c).
In order to determine the effect of the membrane
potential across the inner membrane on mitochondrial
fusion, we added 2 μM of the protonophore CCCP
(carbonylcyanide-3-chlorophenylhydrazone). Fusion was
abolished (Figure 2d) which is in agreement with pre-
vious studies in intact cells [8,23] and the yeast cell-free
mitochondrial fusion assay [5]. To further dissect the
membrane potential requirements, we examined
the effect of valinomycin (1 μM) and nigiricin (2 μM).
Valinomycin is an electrogenic potassium ionophore
which abolishes the charge gradient. Electroneutral
potassium/proton ionophore nigiricin retains the charge,
but ablates the proton gradient. Valinomycin diminished
the fusion reaction by 97%, whereas nigiricin, even at
higher concentrations, inhibited the reaction by only
27% (Figure 2d). We conclude that mammalian mito-
chondrial fusion in vitro requires the charge gradient
across the mitochondrial inner membrane but is inde-
pendent of the chemical gradient.
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Similar to the yeast mitochondrial fusion reaction, the
reaction was efficient in the absence of exogenous cyto-
sol. Nonetheless, there was a profound consequence of
cytosol addition, depending on the state of the cell at
the moment of cytosol preparation. Figure 4a shows
that the addition of 0.1, 0.3 and 3.0 mg/mL (final) cyto-
sol prepared from non-confluent sHeLa cells undergoing
normal proliferation stimulated the reaction in a con-
centration-dependent manner. However, the addition of
0.3 and 3 mg/mL purified placenta cytosol led to an
inhibition of mitochondrialf u s i o ni nad o s e - d e p e n d e n t
manner. This cytosol inhibition was not due to osmotic
effects, since 3 mg/mL BSA (bovine serum albumin) did
not influence the reaction (Figure 4a). The results
demonstrate that the amount of mitochondrial fusion
can be modulated by cytosolic factors either in a nega-
tive or positive way depending on the source of cytosol.
In this way, although we have efficient fusion in the
absence of cytosol, the efficiency of the reaction is cyto-
sol-dependent. One potential difference between pla-
c e n t aa n ds H e L am a yb et h es t a t u so fs i g n a l l i n g
pathways that are activated upon the isolation of cytosol.
In to test whether phosphoproteins may be required for
mitochondrial fusion, we added Shrimp Alkaline Phos-
phatase (SAP) into the reaction. The data show that the
dephosphorylation of proteins leads to a profound and
concentration dependent inhibition of the reaction (Fig-
ure 4b). Heat-inactivated phosphatase was not inhibitory
(Figure 4b).
In order to further probe the impact of signalling
pathways on the fusion reaction, we isolated cytosols
from drug-treated sHeLa cells to activate different path-
ways. We treated sHeLa cells with staurosporin (STS,
1.5 μM) for 6 h to induce apoptosis, collected the apop-
totic cytosol by ultracentrifugation and added it back
into the fusion reaction. As expected from previous stu-
dies [10,24], and the microscopic analysis of treated cells
(Figure 5a), apoptotic cytosol inhibited the fusion reac-
tion (Figure 5b). This demonstrates how cytosolic fac-
tors can modulate mammalian mitochondrial fusion. In
contrast to the inhibition of fusion during cell death, it
has been shown that the activation of protein kinase A
(PKA) through the cAMP pathway leads to the phos-
phorylation of DRP1 and an inhibition of mitochondrial
fission, leading to a more connected mitochondrial reti-
culum [25-27]. Upon addition of 10 μM forskolin to
HeLa cells, we also observed an increased interconnec-
tivity of the mitochondrial reticulum within the first 30
minutes (Figure 5a). In order to test whether this phe-
notype may reflect an increase in fusion that may
accompany DRP1 inhibition, we harvested cytosol from
forskolin-treated sHeLa cells and added this to the cell-
free fusion reaction. Relative to control cytosol,
forskolin-treated cytosol led to a 1.5 - to twofold stimu-
lation in mitochondrial fusion (Figure 5b and 5c). Addi-
tion of forskolin directly into the reaction did not have
any effect on the efficiency of fusion (Figure 5c). Further
incriminating the adenylate cyclase pathway in promot-
ing fusion, stimulation by forskolin could be prevented
by a prior incubation with the PKA inhibitor H89 (1 h,
10 μM; Figure 5c). This confirms that forskolin acts
through the established plasma membrane-bound ade-
nylate cyclase whose downstream signalling mechanisms
converge on the mitochondria to activate mitochondrial
fusion.
Conclusion
Our understanding of both the regulation and the
mechanisms of mitochondrial fusion in mammalian cells
has been limited by the tools available to systematically
dissect the process at the biochemical level. We have
here provided the first automated assay design to quan-
tify mammalian mitochondrial fusion in vitro.O u rd a t a
show that the reaction is physiologically controlled,
requiring energy, temperature and the mitochondrial
inner membrane potential. The fact that our mitochon-
dria are fusogenic in the absence of exogenous cytosol,
and the mitochondrial preparations are relatively free of
cytosol (Additional File 1: Figure S1), suggests that the
core machinery that drives mitochondrial fusion is pri-
marily associated with the mitochondria. However, the
modulation of the reaction by the addition of exogenous
cytosol shows that the reaction is ultimately cytosol-
dependent. The strength of the Renilla luciferase signals
make this assay perfectly suited for screening factors
required for fusion. However, the limitations of this
assay are that we do not differentiate between the early
steps of mitochondrial tethering, docking and the mix-
ing of matrix content. The Nunnari laboratory has
already optimized confocal and EM approaches that
stage the reaction at each step of docking, outer mem-
brane fusion, inner membrane fusion and matrix con-
tent mixing [5-7]. However, that approach remains very
labour intensive. Future assay development could see
the use of these marker pairs on outer membrane or
intermembrane space proteins, which could then allow
us to harness the luciferase-based output in evaluating
each step of mitochondrial fusion.
The evidence that mitochondrial fusion is coupled to
cell signalling pathways has been primarily correlative
with little knowledge of the molecular mechanisms that
underlie these links [1]. Using our cell-free assay system,
we have provided direct evidence that shows how mito-
chondrial fusion is tightly regulated by cytosolic signal-
ing cascades. The stimulationo ff u s i o nu p o na c t i v a t i o n
of adenylate cyclase indicates that the fusion machinery
is integrated within the metabolic status of the cell.
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Page 7 of 12Figure 4 Mitochondrial fusion is modulated by cytosol and phosphorylated proteins. (a) Replacing cytosol with 3 mg/mL bovine serum
albumin or 0.3 - 3 mg/mL placental or HeLa cytosol demonstrates a differential modulation of the fusion reaction depending upon the source.
(b) Addition of 1, 0.1 and 0.001 units of shrimp intestinal phosphatase (SIP) show an absolute requirement for phosphorylated proteins in the
fusion reaction. Heat inactivated SIP did not inhibit the reaction.
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phosphorylation of DRP1 [25-27], leading to the inhibi-
tion of fission activity. Here, our data further demon-
strate that activation of PKA also stimulates fusion. This
is a first step in dissecting the substrates for PKA that
trigger an increase in fusion. Interestingly, the absolute
inhibition of mitochondrial fusion upon the global
dephosphorylation of proteins with SAP also confirms
the importance of phosphorylation cascades in the
regulation of mitochondrial dynamics, providing an
opportunity to screen for kinases and phosphatases that
play key roles in this regulation.
Finally, the addition of apoptotic cytosol to the fusion
reaction leads to an inhibition of mitochondrial fusion
(Figure 4b). It is known that mitochondrial fission is
activated upon cell death, concomitant with a block in
mitochondrial fusion [10,24]. Our assay system con-
firmed this result, further validating this method. More
Figure 5 Signal transduction cascades regulate the mitochondrial fusion reaction. (a) HeLa cells were either untreated (left panels), treated
with 10 μM forskolin for 30 min or with 1.5 μM staurosporin for 4 h were fixed and stained with anti-prdx3 antibodies to label mitochondria.
Bottom panels show a 3× magnification of the boxed areas. Scale bars are 10 μ. (b) Renilla luciferase complementation is shown for
mitochondrial fusion reactions containing 5 mg/mL sHeLa cytosol, or cytosols treated with forskolin or staurosporin, as indicated. The addition of
10 μM forskolin directly to the fusion reaction does not have any effect. Apyrase and 4°C controls are also shown. (b) As in b, including a control
where HeLa cells were incubated with 10 μM forskolin for 30 min in the presence of its inhibitor H89 (10 μM, 1 h pre-incubation) prior to
harvesting the cytosol for addition into the cell free assay.
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to help define the molecular requirements for the apop-
totic inhibition of fusion. In general terms, the adapta-
tion of this assay to high throughput screens, and the
fractionation of cytosols to identify novel fusion factors,
will provide an essential and universal tool for the
advancement of this field.
Methods
Reagents
All chemicals were purchased from Sigma Aldrich (ON,
Canada) unless indicated. ATP*S and GTP*S were
obtained from Jena Biosciences (Jena, Germany). Culture
media, fetal bovine serum and non-essential amino acids
were from Invitrogen (ON, Canada). Anti-prdx3 antibo-
dies were previously described [28]. N-MitoVZL and
C - M i t o L Z Vw e r eu s e da sd e s c r i b e d( H u a n get al.,i n
revision).
Generation of stable sHeLa cell lines
The plasmids encoding N-MitoVZL or C-MitoLZV were
transfected separately into sHeLa cells using Lipofecta-
mine 2000 (Invitrogen, ON, Canada) and the plasmids
left to express for 48 h before adding 2 μg/mL puromy-
cin for 2-3 weeks to select for stably expressing cells.
Total populations were amplified and stored using stan-
dard protocols.
Mitochondrial purification and storage
Stable suspension HeLa lines expressing either N-
MitoVZL or C-MitoLZV were thawed and grown in 3 ×
15 mm dishes with DMEM medium [with 10% fetal
bovine serum (FBS), L-glutamate, non-essential amino
acids and 2 μg/mL puromycin] before they were har-
vested and transferred to 2 L flasks where they were
g r o w ni ns u s p e n s i o ni ns M E M( w i t h1 0 %F B S ,L - g l u t a -
mate, non-essential amino acids and 2 μg/mL puromy-
cin). After 1 L of each culture reached 8 × 10
5 -1 × 10
6
cells/mL, the cells were harvested by 20 min centrifuga-
tion at 3000 × g at 4°C. Keeping all steps at 4°C, the pel-
lets were washed in mitochondrial isolation buffer [MIB;
220 mM Mannitol, 68 mM sucrose, 80 mM KCL, 0.5
mM EGTA, 2 mM Mg(CH3COO)2, 10 mM HEPES pH
7.4, sterile filtered and freshly added protease inhibitors
(Roche Diagnostics, Quebec, Canada) and 2 mg/mL
fatty acid free BSA] and resuspended in 1.5× volumes in
chilled MIB and the cells were ruptured with a glass
dounce homogenizer. The homogenate was centrifuged
for 10 min at 3000 × g at 4°C and the post-nuclear
supernatant (PNS) was isolated. In order to recover
mitochondria that remained trapped in the nuclear pel-
let, the pellet was resuspended again in MIB, centrifuged
at 3000 × g and the PNS was recovered. Mitochondria
were harvested from the PNS by centrifugation of
9000 × g for 15 min at 4°C. The pellet was washed once
in MIB and recentrifuged at 9000 × g. Afterwards, mito-
chondria were resuspended in MIB (lacking BSA) con-
taining 10% glycerol, aliquoted, snap frozen in liquid
nitrogen and stored at -80°C. The protein concentration
was measured with a standard Bradford assay.
Isolation of cytosols
sHeLa cells were grown either on 15 cm dishes in
DMEM medium (including non-essential amino acids,
glutamate and 10% FBS) or in 500mL suspension with
sMEM media (including non-essential amino acids,
L-glutamate and 10% FBS). For untreated cytosol, cells
in suspension were harvested after reaching a density of
8×1 0
5 -1×1 0
6 cells/mL. Cells grown in suspension
were directly harvested by centrifugation.
For the preparation of staurosporin treated cytosol,
the culture was incubated with 1.5 μMS T Sf o r6h ,
whereas forskolin treated cells were incubated with 10
μM forskolin for 30 min before harvesting. In order to
harvest adherent sHeLa cells, the plates were washed
with phosphate buffered saline (PBS), scraped in MIB
and centrifuged for 1 min at 3000 × g at 4°C. The iso-
lated cell pellets were washed in MIB and resuspended
in 1× volume MIB buffer in order to achieve a highly
concentrated cytosol. The cells were homogenized with
a glass dounce homogenizer and the cytosol was cleared
by ultracentrifugation for 40 min at 120,000 × g at 4°C.
The supernatant containing cleared cytosol was ali-
quoted, snap frozen in liquid nitrogen and stored at -80°
C. The protein concentration was measured with the
Bradford method.
For the isolation of human placental cytosol, fresh pla-
centa was minced and washed extensively in phosphate
buffered saline. Washed tissue was homogenized using a
Waring blender, in 2× volume of MIB. The post-nuclear
supernatant was collected from a 3000 × g centrifuga-
tion step for 20 min at 4°C, and the mitochondria were
removed by centrifugation at 9000 × g for 25 min at
4°C. The post mitochondrial supernatant was cleared of
other organelles by ultracentrifugation for 40 min at
120,000 × g at 4°C. The cleared placenta cytosol was
dialyzed twice at 4°C in fusion buffer [35 mM sucrose,
75 mM KCl, 0.5 mM EGTA, 2 mM Mg(CH3COO)2,1 0
mM HEPES, pH 7.4] before it was aliquoted, snap fro-
zen in liquid nitrogen and stored at -80°C. To determine
the protein concentration, the Bradford assay was used.
In Vitro fusion reaction
The in vitro fusion reaction was carried out in 1.5mL
eppendorf tubes. Mitochondria of each population (50
μg each) were added into the reaction with 5mg/mL
cytosol, where the final concentrations of reagents in
the reaction were: 10 mM HEPES pH 7.4, 110 mM
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2m MM g ( C H 3COO)2,0 . 5m MG T P ,2m MK 2HPO4,
1m MA T P ( K
+), 0.08 mM ADP, 5 mM Na succinate
and 1 mM DTT. Mitochondria were concentrated by
centrifugation at 9000 × g for 1 min and incubated on
ice for 30 min. The mixture was then resuspended and
warmed to 37°C for 30 min. Following the reaction, any
signal arising from broken mitochondria was quenched
with 25 μg trypsin on ice for 20 min. Then, trypsin was
inactivated with 500 μg soy bean trypsin inhibitor for an
additional 20 min on ice.
For the Renilla luciferase assays, the trypsinized mito-
chondria were concentrated by centrifugation at 9000 ×
g for 1 min and solubilised with 50 μL of 1× lysis buffer
(Promega, WI, USA) on ice for 1 h. Complementation
of Renilla luciferase is temperature dependent and does
n o tf o r md u r i n gt h es o l u b i l i zation step. The lysate was
placed in 96 well plates where the coelenterazine sub-
strate was injected directly into the reaction in a Glo-
max Luminometer (Promega, WI, USA), following
manufacturer’s instructions. The bioluminescence
photon counts were detected over an integral of 10 s
and the data were analysed with Excel.
Confocal imaging
For the imaging of the Venus complementation, 100 nM
MitoFluorRed633 (Invitrogen, ON, Canada) was added
into the fusion reaction in order to visualize the total
respiring mitochondria. Following trypsinization of the
fusion reaction, the mixture was mixed with 1× volume
of 1.2% low-melt agarose, ensuring that the agarose was
below 35°. This was immediately placed onto a glass
slide and covered with a coverslip to disperse the mito-
chondria evenly. The samples were imaged using an
Olympus IX80 FV1000 confocal microscope, with a
100× NA1.4 objective lens, with the 488nm and 633nm
laser lines to excite the Venus and potentiometric dye
MitofluorRed633, respectively. All images were obtained
using sequential image acquisition under identical con-
ditions and were processed using even thresholding set-
tings. The figures were assembled in Adobe Photoshop;
we applied a 1 pixel Gaussian blur filter within Photo-
shop to better define the mitochondrial signal relative to
the noise.
Electron microscopy
Following the mitochondrial fusion reaction, mitochon-
dria were concentrated by centrifugation at 9000 × g for
1 min and resuspended directly in 1.6% glutaraldehyde in
PBS pH 7.4 for fixation for 1 h at 4°C. The fixed mito-
chondrial pellet was then resuspended in 15%BSA in PBS
containing 1.2% low melt agarose, recentrifuged and the
resulting pellet cut into 1 mm pieces. The samples were
then postfixed in 1% osmium tetroxide in 0.1 M na
cacodylate buffer, en bloc stained in 3% aqueous uranyl
acetate, dehydrated in ascending ethanol and embedding
in Spurr epoxy resin. Ultra thin sections were cut on a
Reichert Ultracut E ultramicrotome. Digital images were
taken using a JEOL 1230 TEM at 60 kV adapted with a
2000 by 2000 pixel bottom mount CCD digital camera
(Hamamatsu, Japan) and AMT software.
Additional material
Additional file 1: Supplemental figures S1 and S2. Supplementary
figures.
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